The Latest SPAC News and Rumors: September 15, 2021
by Marlena Haddad on 2021-09-15 at 11:51am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Carousell becomes Singapore’s newest unicorn, Acorns names former Amazon executive as president, and Anghami partners with Amazon Prime


Online Marketplace Carousell Is Singapore’s Newest Unicorn

Online classifieds marketplace Carousell Pte became Singapore’s latest tech unicorn, raising funds at a $1.1 billion valuation as Southeast Asia’s e-commerce startups benefit from the pandemic and related lockdowns, according to Bloomberg.

The company got $100 million in a round led by South Korean private equity firm STIC Investments.

Carousell has weighed a U.S. listing via a merger with a blank-check company, people with knowledge of the matter said in June.

READ

Acorns Names Amazon Alum David Hijirida as President Ahead of IPO

Acorns Grow Inc. hired former Amazon.com Inc. executive David Hijirida as its president, as the savings and investing startup prepares to go public by merging with a blank-check company.

On May 27, Acorns entered into a definitive agreement to combine with Pioneer Merger Corp. (NASDAQ:PACX).

READ

Amazon Prime and Anghami Collaborate in Saudi Arabia and United Arab Emirates with Anghami Plus

Amazon and Anghami have today announced that Amazon Prime members in Saudi Arabia and the UAE can enjoy an exclusive six-months free offer on Anghami Plus, Anghami’s premium paid tier, with their Prime membership.

Prime members in Saudi Arabia and the UAE will receive a free six-month subscription to Anghami Plus, followed by 50% off the subscription fee for the next six months.

On March 3, Anghami entered into a definitive agreement to combine with Vistas Media (NASDAQ:VMAC).

READ

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza  

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced the completion of enrollment in its Phase 2a clinical trial evaluating the safety and efficacy of SAB-176 in a challenge study.

SAB-176 is a novel anti-influenza human immunotherapy designed to address the limitations of current treatments for moderate to severe seasonal influenza.

On June 22, SAB announced a planned merger with Big Cypress Acquisition Corp. (NASDAQ: BCYP).

READ

Recent Posts
by Nicholas Alan Clayton on 2024-11-04 at 1:57pm

Cantor Equity Partners I, Inc. (NASDAQ:CEPO) has filed for a $200 million IPO with near identical terms to its sister SPAC Cantor Equity Partners, Cantor Equity Partners (NASDAQ:CEP), giving the team a second vehicle in the mix with terms designed to be particularly attractive to targets. It would be the fourth SPAC to IPO in...

by Kristi Marvin on 2024-11-04 at 8:13am

This week, we speak with Betsy Cohen and Maxwell Smeal from the Cohen Circle Acquisition Corp. I team to get their views on the current SPAC landscape. Betsy Cohen is already a well-known figure in SPAC circles for having previously led the Fintech Acquisition and FTAC SPACs. Betsy and Max discuss the past, present and...

by Nicholas Alan Clayton on 2024-11-04 at 8:12am

At the SPAC of Dawn The first full week of November is expected to be action-packed as SPAC shareholders will be turning in scores of ballots of their own amid the US election week. The next five days are to play host to 10 extension meetings and a pair of completion votes by Atlantic Coastal...

by Kristi Marvin on 2024-11-02 at 10:01am

Terms Tracker for the Week Ending November 1, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Once again, the past week was all about new issuance while the DeSPAC announcements remain quiet. To kick off November, two SPACs priced IPOs to...

by Anthony Sozzi on 2024-11-01 at 3:47pm

October continued the recent trend of SPAC teams seeking additional extensions beyond their first one, as they work on closing their combinations with the remaining funds after redemptions. Meanwhile, new SPACs are launching IPOs and beginning their search processes, signaling a shift in the market. Extension Votes In October, there were 13 scheduled extension votes....

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved